Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs.

Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial Intelligence.

Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is ...

Isomorphic Labs, the AI -powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI.

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 million.

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling breakthroughs.

HIGHLIGHTS Isomorphic Labs is nearing human clinical trials for drugs developed using AI. Isomorphic helps pharma partners with their drug development programs while also working on its own ...

Crystal Palace “would rather take £50million up front” for Marc Guehi from Liverpool than a swap deal involving Ben Doak, according to reports.

Both the prosecution and defense have presented all evidence in the joint trial against two men charged in connection to the disappearance of missing Bardstown mother, Crystal Rogers. Houck, 43 ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.

The second murder trial of Brooks Houck and Joseph Lawson is now in its third week in Bowling Green 10 years after Crystal Rogers disappeared in Bardstown.